TY - JOUR T1 - Pain Reduction by Inducing Sensory-Motor Adaptation in Complex Regional Pain Syndrome (CRPS PRISMA): Protocol for a Double-blind Randomized Controlled Trial JF - medRxiv DO - 10.1101/19000653 SP - 19000653 AU - Monika Halicka AU - Axel D Vittersø AU - Michael J Proulx AU - Janet H Bultitude Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/01/03/19000653.abstract N2 - Background Complex Regional Pain Syndrome (CRPS) presents as chronic, continuous pain and sensory, autonomic, and motor abnormalities affecting one or more extremities. People with CRPS can also show changes in their perception of and attention to the affected body part and sensory information in the affected side of space. Prism Adaptation (PA) is a behavioural intervention targeted at reducing attention deficits in post-stroke hemispatial neglect. PA also appears to reduce pain and other CRPS symptoms; however, these therapeutic effects have been demonstrated only in small unblinded studies. This paper describes the protocol for an ongoing double-blind, randomized, sham-controlled clinical trial that will evaluate the efficacy of PA treatment for CRPS. The secondary aims of the study are to examine the relationships between neuropsychological changes (such as spatial attention, space and body representation, and motor spatial performance) and clinical manifestations of CRPS, as well as symptom improvement.Methods Forty-two participants with upper-limb CRPS type I will undergo two weeks of twice-daily PA treatment or sham treatment. The primary outcome measures are current pain intensity and CRPS severity score, measured immediately before and after the treatment period. Secondary outcome measures include the results of self-report questionnaires about pain, movement, symptoms interference, and body representation; clinical assessments of sensory, motor, and autonomic functions; and computer-based psychophysical tests of neuropsychological functions. Data are collected in four research visits: four weeks and one day before treatment, and one day and four weeks after the end of treatment. Additional follow-up through postal questionnaires is conducted three and six months post-treatment.Discussion It is hypothesised that participants undergoing PA treatment, compared to those receiving sham treatment, will show greater reduction in pain and CRPS severity score, and improvements on other clinical and neuropsychological measures. Also, more pronounced neuropsychological symptoms are predicted to correlate with more severe clinical CRPS symptoms. This study will provide the first randomized double-blind evaluation of the therapeutic effects of PA that could be implemented as a rehabilitation method for CRPS, and will contribute to the understanding of how neuropsychological changes in body representation and attention pertain to the manifestation and treatment of CRPS.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN46828292Clinical Protocols http://www.isrctn.com/ISRCTN46828292 Funding StatementThe study is funded by Reflex Sympathetic Dystrophy Syndrome Association (RSDSA). The RSDSA approved the design of the study and have no other role regarding the use of the data or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesThere is no data associated with the current paper, which describes a protocol for a clinical trial that is in progress at the time of submission. All investigators will have access to the final dataset. Anonymised participant-level data from the trial will be stored using the Open Science Framework repository and access will be granted upon request. Access shall be requested by contacting the corresponding author via email. Description of the data and specific instructions for gaining access will be listed in a publicly-available format in the repository. The data will be made available in this format at the time that the paper describing the trial outcome is published, upon MH’s graduation from her PhD, or two years after the end of data collection (whichever comes first).BPDSBath CRPS Body Perception Disturbance ScaleBPIBrief Pain InventoryCRPSComplex Regional Pain SyndromeFTPFinger-To-Palm distanceLTFU1Long Term Follow-Up 1 (week 19) by postLTFU2Long Term Follow-Up 2 (week 31) by postMDTMechanical Detection ThresholdMETMovement Execution TimeMITMovement Initiation TimeMPTMechanical Pain ThresholdNRSNumerical Rating ScalePAPrism AdaptationPSEPoint of Subjective EqualityPSSPoint of Subjective SimultaneityRS1Research Session 1 (week 1)RS2Research Session 2 (week 4)RS3Research Session 3 (week 7)RS4Research Session 4 (week 11)RSDSAReflex Sympathetic Dystrophy Syndrome AssociationRTReaction TimeQSTQuantitative Sensory TestingTOJTemporal Order JudgementVFVisual Field ER -